Theralase Technologies Inc

CVE:TLT ISIN:CA88337V1004

 Theralase Technologies Inc (CVE:TLT) (OTCMKTS:TLTFF)laser technology used in eliminating pain and destroying cancer. Theralase technology is safe and effective in eliminating pain, reducing inflammation and accelerating tissue regeneration of numerous nerve, muscle and joint conditions. Theralase is actively developing patented technology that is able to target and destroy cancers, bacteria and viruses when light activated.
 
 

News

Theralase Technologies Inc. (CVE:TLT) (OTCMKTS:TLTFF) Discovers Anti-Cancer Memory Response

🕔6/2/2014 11:56:01 AM 4936

Theralase Technologies Inc. (CVE:TLT) (OTCMKTS:TLTFF) announced today that in preclinical animal testing, performed at Princess Margaret Cancer Centre, University Health Network ("UHN"), it has discovered that its lead Photo Dynamic Compound (PDC), intended for the destruction of cancer, has demonstrated an ability to render animals immune to repeated exposures of the same cancer.

Read Full Article
###

3,742 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 17) (Since Published: 3742) 

Company Data

    Headquarters
  • 1945 Queen Street East
    Toronto, Ontario
    M4L 1H7,
    Canada
  • Telephone
  • +1-416-699-5273 
  • Fax
  • +1-416-699-5250 
  • Principal Sector
  • Health & Pharm General 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.theralase.com
  • E:
  • rwhite@theralase.com